Highlights•mAbs are suitable to replace rabies immunoglobulins in rabies prophylaxis.•mAb
cocktails are recommended to limit the risk of failure due limited coverage and viral …

Nations' ongoing struggles with a number of novel and reemerging infectious diseases,
including the ongoing global health issue, the SARS-Co-V2 (severe acute respiratory …

Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly
developed to help restore the massive health and economic disruption caused by the …

Background Malaria elimination requires interruption of the highly efficient transmission of
Plasmodium parasites by mosquitoes. TB31F is a humanised monoclonal antibody that …

Understanding mechanisms of antibody synergy is important for vaccine design and
antibody cocktail development. Examples of synergy between antibodies are well …

Immunotherapies are disease management strategies that target or manipulate components
of the immune system. Infectious diseases pose a significant threat to human health as …

Malaria parasite transmission to mosquitoes relies on the uptake of sexual stage parasites
during a blood meal and subsequent formation of oocysts on the mosquito midgut wall …

ABSTRACT COVID-19 caused by the virus SARS-CoV-2 has gripped essentially all
countries in the world, and has infected millions and killed hundreds of thousands of people …

For decades, immunoglobulin preparations have been used to prevent or treat infectious
diseases. Since only a few years, monoclonal antibody applications (mAbs) are taking flight …

Prolonged maintenance of therapeutically-relevant levels of broadly neutralizing antibodies
(bnAbs) is necessary to enable passive immunization against infectious disease …